Brief #25226Updated 18 JUN 2026SAN DIEGOMEDICAL ORGANIZATIONSSERIES B
Employbl DossierSidewinder Therapeutics
Sidewinder Therapeutics develops bispecific antibody-drug conjugates (ADCs) aimed at treating solid tumors. Their mission is to create life-saving therapies through precision therapeutics.
- Founded
- 2023
- Headcount
- 12
- Open roles
- 0
- Last raised
- Series B · $137M
Section II · Premium ProfileMembers only
- 01Engineering interview process at Sidewinder TherapeuticsLocked
- 02Tech stack & infrastructure choicesLocked
- 03Culture & day-to-day work styleLocked
- 04Why join now vs. 6 months from nowLocked
- 05Hiring focus & open headcount by teamLocked
- 06Comp philosophy and band contextLocked
7-day free trial · $25/mo · cancel anytime
